Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

14 Oct 2024

Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease.

Source: BSE India

View all announcements for Zydus Lifesciences Ltd